MedPath

Prosidion Ltd.

🇬🇧United Kingdom
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)

Phase 2
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2011-06-30
Last Posted Date
2012-08-17
Lead Sponsor
Prosidion Ltd.
Target Recruit Count
66
Registration Number
NCT01386099
Locations
🇿🇦

Parexel George, George, South Africa

🇿🇦

Parexel Bloemfontein, Bloemfontein, South Africa

🇿🇦

Synexus Clinical Research SA (Pty) Ltd, Pretoria, Gauteng, South Africa

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath